1. Home
  2. CIX vs ACRS Comparison

CIX vs ACRS Comparison

Compare CIX & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$24.30

Market Cap

289.5M

ML Signal

N/A

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.52

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
ACRS
Founded
1993
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.5M
311.0M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
CIX
ACRS
Price
$24.30
$3.52
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.75
AVG Volume (30 Days)
1.9K
2.3M
Earning Date
06-04-2026
05-27-2026
Dividend Yield
9.05%
N/A
EPS Growth
17.04
69.01
EPS
1.58
N/A
Revenue
$158,285,000.00
$1,683,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.38
N/A
Revenue Growth
8.46
N/A
52 Week Low
$17.89
$1.05
52 Week High
$32.30
$4.89

Technical Indicators

Market Signals
Indicator
CIX
ACRS
Relative Strength Index (RSI) 51.26 55.72
Support Level $22.97 $2.76
Resistance Level $24.90 $3.78
Average True Range (ATR) 0.37 0.23
MACD -0.05 0.05
Stochastic Oscillator 43.13 76.26

Price Performance

Historical Comparison
CIX
ACRS

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: